Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
FUSN | A | Fusion Pharmaceuticals Inc. | 0.09 | |
LDOS | A | Leidos Holdings, Inc. | 0.37 | |
DCTH | B | Delcath Systems, Inc. | 0.76 | |
CRVO | B | CervoMed Inc. | -4.68 | |
NKTR | B | Nektar Therapeutics | 0.00 | |
VNDA | B | Vanda Pharmaceuticals Inc. | 3.13 | |
MACK | B | Merrimack Pharmaceuticals, Inc. | 0.00 | |
XTLB | B | XTL Biopharmaceuticals Ltd. | 0.92 | |
SRPT | B | Sarepta Therapeutics, Inc. | 1.08 | |
LIXT | B | Lixte Biotechnology Holdings, Inc. | 1.24 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PINK | C | Simplify Health Care ETF | 8.61 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 5.35 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.86 | |
SHLD | A | Global X Defense Tech ETF | 4.52 | |
MISL | A | First Trust Indxx Aerospace & Defense ETF | 4.38 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles